Public Release: 

Latest research findings on urologic disease to be presented at 2000 American Urological Association annual meeting

American Urological Association

Scheduled for April 29 -- May 4 in Atlanta

More than 1,500 original research studies on the prevention, diagnosis, treatment, and management of urologic diseases plus state-of-the-art plenary session presentations highlight the program for the 2000 American Urological Association Annual Meeting, scheduled for April 29 -- May 4 at Atlanta's Georgia World Congress Center.

More than 8,000 urologists will attend the meeting‹the largest and most comprehensive annual forum devoted exclusively to urology. Total attendance is expected to exceed 14,000 registrants, including non-urologist physicians, biomedical researchers and health care professionals. In addition to numerous podium and poster sessions at which new research findings will be presented, meeting registrants will be able to attend state-of-the-art lectures, panel discussions, point/counterpoint debates on controversial issues in urology, continuing education courses, and a exposition of over 300 exhibits demonstrating the latest products and technology of interest to urologists.

During the meeting, new research findings and state-of-the-art information will be presented on all urologic diseases, including prostate cancer, male and female sexual dysfunction, incontinence, benign prostatic hyperplasia or enlarged prostate, kidney stone disease, bladder cancer, testicular cancer, kidney cancer and infertility.

Highlights of the plenary program include:

  • Panel discussion on "Advances in Bladder Augmentation and Replacement," scheduled for Sunday, April 30 at 10:50 a.m. Panelists include Dr. Terry W. Hensle of the Babies Hospital in New York City, Dr. Anthony Atala of the Children's Hospital in Boston, Dr. Bradley P. Kropp of the University of Oklahoma, and Dr. Richard C. Rink of the Riley Hospital for Children at the University of Indiana Medical Center.
  • State-of-the-art lecture by Dr. Mark S. Litwin of the University of California, Los Angeles on "Prostatitis: Changing Concepts," scheduled for Sunday, April 30 at 11:25 a.m.
  • Point/counterpoint discussion on "Stress Urinary Incontinence: Approaches to Evaluation and Management," scheduled for Monday, May 1 at 8 a.m. The discussion will be moderated by Dr. Alan J. Wein from the Hospital of the University of Pennsylvania in Philadelphia, and the subject will be discussed by Dr. Paul Abrams from Bristol, England and Dr. Robert J. Krane from Boston University Medical Center.
  • State-of-the-art lecture by Dr. Michael J. Droller of the Mount Sinai Medical Center in New York City on "Molecular Markers in Diagnosis of Carcinoma of the Bladder," scheduled for Monday, May 1 at 8:20 a.m.
  • State-of-the-art lecture by Dr. Lawrence H. Einhorn of the Indiana Cancer Pavilion in Indianapolis on "The Management of Testicular Cancer," scheduled for Monday, May 1 at 9:30 a.m.
  • State-of-the-art lecture by Dr. William R. Fair of Memorial Sloan-Kettering Cancer Center in New York City on "Alternative/Complementary Medicine: Current Approaches," scheduled for Monday, May 1 at 11:45 a.m.
  • State-of-the-art lecture by Dr. Gary E. Leach of the Tower Urology Institute for Continence in Los Angeles on "Sling Procedures for Stress Urinary Incontinence," scheduled for Tuesday, May 2 at 8 a.m.
  • State-of-the-art lecture by Dr. Howard I. Scher of Memorial Sloan-Kettering Cancer Center in New York City on "New Approaches to Hormonal Management in Carcinoma of the Prostate," scheduled for Tuesday, May 2 at 8:20 a.m.
  • Panel discussion on "Renal Cell Carcinoma: Clinical Problems," scheduled for Tuesday, May 2 at 8:40 a.m. Panel members include Dr. Jerome P. Richie from Brigham & Women's Hospital in Boston, Dr. Rolf Ackerman from the University of Dusseldorf, Dr. Steven C. Campbell from Northwestern University, Jean B. deKernion from the University of California, Los Angeles, and Dr. Robert C. Flanigan from Loyola University Medical Center.
  • Point/counterpoint discussion on "Management of T3 Cancer of the Prostate," scheduled for Wednesday, May 3 at 8:40 a.m. The moderator of this discussion will be Dr. Andrew C. von Eschenbach of the University of Texas M.D. Anderson Cancer Center. The subject will be discussed by Dr. William J. Catalona from the Washington University Medical Center in St. Louis and Dr. William U. Shipley from the Massachusetts General Hospital Cancer Center in Boston.
  • The John K. Lattimer Lecture will be presented on Wednesday, May 3 at 9:10 a.m. by Dr. Thomas A. Stamey of Stanford Medical Center, who will discuss "Prostate Cancer: Predicting Outcomes."
  • The Ramon Guiteras Lecture will be presented on Wednesday, May 3 at 11:25 a.m. by Dr. Ralph V. Clayman of Applied Medical Resources, who will discuss "Surgical Implosion: The Waning of the Wound." Being invited to present the Guiteras Lecture represents one of the most prestigious honors that takes place at each AUA Annual Meeting.

Some of the important new research findings scheduled to be presented at the meeting include:

  • Latest data on the high costs of prostate cancer.
  • Data that addresses the relationship between prostate specific antigen (PSA) screening and prostate cancer mortality.
  • The quality of life after radical prostatectomy vs. brachtherapy for localized prostate cancer.
  • Outcomes information on sexual function after Cavermap™ assisted nerve-sparing radical prostatectomy.
  • Data that shows topical alprostadil produces significant clitoral hemodynamic changes.
  • Outcomes data on the effects of sildenafil on sexual function in hysterectomy patients.
  • The efficacy and safety of apomorphine for erectile dysfunction in patients with coronary artery disease.
  • Latest information on penile reconstruction using engineered corporal tissue.

###

For more information about the AUA Annual Meeting, please contact Bill Glitz by phone at 703-532-3797 or by email at wglitz@aol.com; or Lisa Goetz by phone at 410-223-6402 or by email at lgoetz@auanet.org. The telephone number for the press room in Atlanta is 404-222-5203. It will be activated on April 28 and discontinued at 12 noon on May 4.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.